ALX Oncology to present at investor conferences in September
ALX Oncology Holdings said its leadership will present at upcoming investor conferences in September, according to a company announcement.
SOUTH SAN FRANCISCO, Calif., Sept.
02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership…